Your browser doesn't support javascript.
loading
Case Report: Exceptional Response to Nivolumab Plus Ipilimumab in a Young Woman With TFE3-SFPQ Fusion Translocation-Associated Renal Cell Carcinoma.
Martini, Dylan J; Jansen, Caroline S; Harik, Lara R; Evans, Sean T; Olsen, T Anders; Master, Viraj A; Kissick, Haydn T; Bilen, Mehmet Asim.
Affiliation
  • Martini DJ; Department of Medicine, Massachusetts General Hospital, Boston, MA, United States.
  • Jansen CS; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, United States.
  • Harik LR; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, United States.
  • Evans ST; Department of Urology, Emory University School of Medicine, Atlanta, GA, United States.
  • Olsen TA; Department of Pathology, Emory University School of Medicine, Atlanta, GA, United States.
  • Master VA; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, United States.
  • Kissick HT; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, United States.
  • Bilen MA; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, United States.
Front Oncol ; 11: 793808, 2021.
Article in En | MEDLINE | ID: mdl-34976834
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Front Oncol Year: 2021 Document type: Article Affiliation country: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Front Oncol Year: 2021 Document type: Article Affiliation country: Estados Unidos